Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says [W[R]C]
Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome, and the US Food and Drug Administration has asked Pfizer to conduct a safety study if the shot is approved, according to agency documents released Friday.
Sponsored by The BlogDealer – Health, Fitness and Fat Reduction.
Listen to “Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says [W[R]C]” on Spreaker.Source: CNN
https://www.cnn.com/2023/02/24/health/pfizer-rsv-vaccine-guillain-barre/index.html
